Company Filing History:
Years Active: 2023
Title: Innovations of Christopher Charles Kemball in Biotechnology
Introduction
Christopher Charles Kemball is a notable inventor based in El Cerrito, California. His work primarily focuses on innovative solutions in the biotechnology field, contributing to advancements in therapeutic proteins. With a remarkable patent portfolio, he exemplifies the role of inventors in transforming scientific ideas into impactful technologies.
Latest Patents
Kemball holds a significant patent related to FLT3 ligand fusion proteins and methods of use. This patent outlines an effectorless immunoglobulin Fc protein and describes the fusion of this effectorless Fc protein to a FLT3 ligand, along with methods of utilizing the innovation. Such advancements are crucial for developing new therapeutic interventions, especially in cancer treatment.
Career Highlights
Currently, Kemball is associated with Genentech, Inc., a leading biotechnology company known for its groundbreaking research and development in pharmaceuticals. His contributions at Genentech underscore his commitment to advancing medical science through innovative research.
Collaborations
Throughout his career, Kemball has worked alongside esteemed colleagues such as Yichin Liu and Christine Carine Moussion. These collaborations reflect a strong network of professionals dedicated to pushing the boundaries of biotechnological research and development.
Conclusion
In conclusion, Christopher Charles Kemball's contributions to biotechnology, particularly through his patent on FLT3 ligand fusion proteins, showcase his innovative spirit and commitment to advancing medical science. His work at Genentech and collaboration with talented individuals further solidify his standing as an influential inventor in the field.